SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " BIO " 2,838 found 🔀 AI-powered Shuffle
Seventy Years of Microbiome Science in China Signals a One Health Future
Trillions of microorganisms live on and inside the human body, in the soil that grows our food, and in the rivers, oceans and air that surround us. While microbes are most often discussed in the context of infection and disease, the vast majority of these organisms are neither
Information in Biology: A Mystery for Naturalism
Biology was giving us computer programming and symbolic codes which, by mapping functional structures to functional structures, exhibited a tacit semantics.
The 2011 Japan Tsunami Created Hybrid Fish, But They Almost Completely Disappeared
A changing world is pushing species boundaries in unusual ways, and the tsunami gave marine biologists a view of the process vastly sped up
This simple diet change could slow your biological age in just four weeks, study suggests
A simple change to the balance of your diet could reduce your biological age in just four weeks, according to a new study
I Had 5 Key Pillars of Health Tested, in Less Than Six Hours
With two Biograph locations, one in New York and one in the San Francisco bay area, the preventative care clinics evaluate assessments across five key pillars of health.
Margaret Qualley, Sabrina Carpenter Cast In Tom Holland's Fred Astaire Film
Margaret Qualley and Sabrina Carpenter have joined Tom Holland in Paul King's untitled Fred Astaire biopic, Deadline reports.
NeuroSense Provides Business Update and Progress for the First Half of 2026
/PRNewswire/ -- Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense" or the "Company"), a late-stage clinical biotechnology company focused on developing...
From fertility to menopause: Women's health workshop in Miami aims to empower women through education
Biohack-It is hosting a women’s health workshop and panel in Miami on Sunday, Oct. 4, featuring fertility specialist Dr. Natalie Crawford and OB-GYN Dr. Jessica Shepherd.
Biologists move unprecedented Orange County sea turtle eggs to protect them from hurricane-driven waves
The olive ridley sea turtle eggs will incubate at the Aquarium of the Pacific
Stunned scientists discover new wild cat species after a century—see the photos - Futura-Sciences
A Mysterious Cat in the Clouds High in the Andean forests—almost always wrapped in mist—a pint-sized cat was living its life unnoticed by the scientific community, although locals might have crossed its path many times. The story kicked off in 2016, when a Bolivian animal shelter contacted biologist Paola Nogales-Ascarrunz...
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time gene therapy for Sanfilippo syndrome type A, an inherited disease that progressively destroys cognitive function in young children. Until this week, there was no approved treatment at all. BioNTech’s lung cancer candidate shows promising results. […]
BioHealth Capital Region - Regional Life Sciences Roundup - September 25, 2026
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising…
Margaret Atwood donates $1-million to establish research chair for bird science
Donation will allow Western University to add a new hire to its biology faculty with the goal of advancing scientific knowledge about birds and bird migration
Pioneer of China NewCo model sued in US over trade secret misuse, double-dealing
A legal feud unfolding in New York is putting a spotlight on the work of a business development veteran who is credited for pioneering one of biopharma’s hottest dealmaking mechanism: the China “NewCo” model. In a lawsuit originally filed in New York state court and recently moved to federal court, China’s Lepu Medical Technology has alleged that biopharma business development consultant Su Zhang, who was hired to help shop its GLP-1 weight-loss candidates to Western partners, engaged in corporate double-dealing and trade secret leaks. According to the complaint, while acting as Lepu’s primary dealmaking liaison for a group of obesity and metabolic disease drug candidates, Zhang was secretly double-dipping as the acting chief business officer for a direct competitor, BrightGene Pharmaceutical. “She never adequately disclosed the role, never sought Lepu’s consent, and never proposed any safeguard,” Lepu alleged in its complaint, which was filed in July after Zhang’s consulting firm, CoDevCo, sought certain transaction-based success fees from its angry customer through an arbitration process in Singapore. Lepu, the parent company of Lepu Biopharma, has asked Zhang to pay back its $500,000 retainer and disgorge all benefits she received during the alleged breaches of fiduciary duty, plus other damages and relief. The company has also requested the court grant injunctions to protect Lepu’s trade secrets. The ill-fated partnership officially kicked off in December 2024, when Lepu tapped CoDevCo as its “exclusive business development mechanism” to identify collaborators for the company’s drug candidates. According to Lepu’s complaint, Zhang personally negotiated and signed the agreement as managing director for CoDevCo, which used her home address. Before the Lepu deal, Zhang made a name following a short stint as the global head of business development for Hengrui Pharmaceuticals. It was during her tenure that Hengrui signed a landmark deal granting exclusive rights for a portfolio of GLP-1 assets to Hercules, which was at that time newly established by a group of private equity and venture capital firms. In addition to the regular upfront and milestone payments, Hengrui also gained an equity stake in Hercules, which later became Kailera Therapeutics. The Hengrui-Hercules deal opened a new paradigm, where a Chinese biopharma company spins off certain early-stage assets to investors for further development through the creation of a new company abroad. The “NewCo” model quickly came into vogue as it allows Western investors to access high-potential assets originating from China at an early stage while giving the Chinese licensors an opportunity to reap long-term benefits through equity stakes in the new firms. The NewCo model proved its value when Kailera staged a record-breaking $625 million IPO on Nasdaq this April, merely two years into the Hengrui deal. Related Kailera CEO 'knew we were in a good spot' before obesity biotech's record-breaking $625M IPO On her LinkedIn page, Zhang described her work at Hengrui as “[b]uilding team and capability from the ground up,” forming NewCo and major pharma partnerships worth billions of dollars. Lepu clearly wanted that kind of track record to help boost its own cardiometabolic portfolio, which includes a range of assets for obesity, Type 2 diabetes, fatty liver disease and muscle preservation during weight loss treatment. “Lepu’s pipeline is very valuable, but only if Lepu could secure the right international partner to expand into the overseas market during the available commercial window,” the company argued in its complaint. The Chinese biotech said it had little knowledge of U.S. laws, customs or business practices in the business development field, and therefore “needed to rely entirely” on the expertise of Zhang and her team as the firm’s first engagement of a U.S.-based BD consultant. “Zhang’s dominating influence on the business development strategy is further evidenced by the fact that she personally controlled the business-development communications on behalf of Lepu with potential partners,” Lepu said in its complaint. After entering the deal, Zhang introduced Lepu to her four associates. According to Lepu’s version of events, all of them were allegedly employed at different time points to perform similar jobs at other Chinese companies that Lepu described as its competitors, while having access to Lepu’s confidential information. As such, Lepu described Zhang’s team as “a roster of individuals whose primary professional loyalty, by virtue of their concurrent full-time employment, ran to Lepu’s competitors.” As well as the specific examples set out in the case, a look at Lepu’s deals over the period suggests Zhang may have been involved in at least one transaction. During their partnership, Lepu, through its subsidiary Shanghai Minwei Biotechnology, also out-licensed its GLP-1/GIP/FGF21 agonist MWN105 to a NewCo called Sidera Bio in the fall of 2025. The deal included an upfront and near-term payment of $35 million, up to $1.01 billion in milestones, and a 9.99% stake in the Danish startup. It seems likely that Zhang facilitated the Minwei deal given that Lepu is on record as having used CoDevCo as its “exclusive business development mechanism.” The big shock for Lepu came in the form of a news article on June 25, 2025. The article, reporting on phase 2 data for BrightGene’s GLP-1/GIP receptor agonist BGM0504, identified Zhang as acting chief business officer of the Lepu rival. Blindsided by her association with BrightGene, Lepu confronted Zhang in July 2025. “Lepu was given assurances that there was nothing to be concerned about and told that Zhang would explain the matter to Lepu,” Lepu alleged in its complaint. “Zhang never did.” Lepu claimed that Zhang had the motive and opportunity to steer potential prospective partners toward BrightGene or other competitors. Later, in February 2026, one of Zhang’s associates joined BrightGene as the vice president for global business development, according to the complaint. Around the same time, Lepu sent written demand letters asking Zhang to account for her BrightGene role, identify what confidential data were shared with the rival firm, and provide any conflict-of-interest or firewall policies during the engagement. According to Lepu, neither CoDevCo nor Zhang answered the questions in their responses. Related Novo vs. KBP: How a $1.3B deal turned into a fraud accusation and an international legal fight In a motion to dismiss filed with the U.S. District Court in the Eastern District of New York on Sept. 4, Zhang’s legal team argued that Lepu’s agreement was signed with CoDevCo, and that an employee of the contractor does not owe fiduciary duties to the client. In its complaint, Lepu said: “That CoDevCo was the contracting entity does not insulate Zhang from personal liability for duties she personally undertook and personally breached.” Taking the argument one step further, the defending party argued that the consulting agreement “does not create a fiduciary relationship even between CoDevCo and Lepu; instead, it identifies CoDevCo as an independent contractor retained to market Lepu’s business to potential western partners.” Although CoDevCo was Lepu’s exclusive business-development contractor, there were no terms stipulating that the consulting firm should serve only Lepu, Zhang’s lawyer noted. As to Lepu’s claims that Zhang misappropriated trade secrets, the defendant argued that Lepu authorized the use of the information so Zhang’s team could perform their service per the agreement. In a rebuttal filed on Sept. 11, Lepu’s lawyer set out why they believe the Chinese biotech satisfied New York law’s misappropriation definition by alleging that the defendant used a trade secret “in breach of a duty or through improper means.” As an alternative to dismissing the suit, the defendant suggested the action should be stayed pending outcomes from the arbitration of a separate case in Singapore. While NewCo pioneer Zhang is defending her business arrangements, momentum behind the NewCo trend has continued unabated into 2026. Through August, Chinese biotech assets have spurred 15 NewCo deals this year, according to local trade publication PharmaDJ.
DelVal's Food Science Program Offers Hands-On Path to an In-Demand Industry
DelVal’s Food Science and Technology Program combines biology, chemistry, and food while preparing students for careers in a growing ...
ACSH in the media: British Medical Journal, RealClearScience (and Health), plus more podcasts
From a weedkiller paper that cannot carry the weight of its headline to a PFAS rule that treats cookware like a biohazard, we've been busy. Here’s a look at some of our recent media appearances, including in the British Medical Journal (BMJ), RealClearHealth, RealClearScience, SacTown Talks and the Health Policy Podcast.
Jonathan Fortney, Dan Costa honored by American Geophysical Union
Astronomy and astrophysics professor Jonathan Fortney receives 2026 Whipple Award and ecology and evolutionary biology professor Dan Costa named 2026 AGU Union Fellow
MSU College of Letters and Science Distinguished Professor to talk about pursuing passions and excellence in Oct. 8 lecture
Brian Bothner will reflect on a career advancing biomedical research, mentoring students and expanding scientific opportunities across Montana in a free, public lecture at the Museum of the Rockies on Oct. 8.
Intense Media Pressure an Emerging Challenge in CHO Business
Growing culture media requirements are becoming a major logistical and storage challenge for biopharmaceutical manufacturers.
Reedijk 'not an academic guy' despite doctorate
New Hibernian manager Marink Reedijk insists he is more a man of action than an academic despite having a philosophy doctorate in sports coaching. The Dutchman is only 35 but had already worked in coaching with Ajax and West Bromwich Albion, Roeselare, Vitesse and Anderlecht before leading Beveren to the Belgian second-tier title and promotion last season. "I'm not a really an academic guy," he told Hibs TV.
Blowhole nebulizer helps cure beluga whale's pneumonia
The vets needed to get creative when antibiotics weren’t moving the needle for her chronic condition.
AC Milan consider Adrien Rabiot contract extension a priority
AC Milan have reportedly made extending the contract of Adrien Rabiot (31) their top priority, according to reports in La Gazzetta dello Sport.Under contract with the Lombardy-based club until 2028, t...
'It's Not Great Content': Ex-Dragon Age Exec Says He'd Now Change or Ditch Several Key Moments From the Series
Former Dragon Age exec Mark Darrah has revealed what he'd change about BioWare's beloved fantasy series, after spending more than 20 years at the studio.
Generic, Biosimilar Medicines Saved US Health Care $496B in 2025
The Association for Accessible Medicines report, prepared with the IQVIA Institute, also reports $25.4 billion in biosimilar savings for the year.
In a New Anthropic Lab, A.I. Turns to Biology
Scientists at the company announced their first finding: a group of enzymes whose function is unknown.
Babis Kostoulas: A Deserved Nomination
On the 12th of June 2025, Brighton and Hove Albion signed Babis Kostoulas from Olympiacos. Since that moment, the Greek striker has treated Albion fans to tricks, bicycle kicks, and a thoroughly deserved Player of the Month nomination.
How Open Science Can Help Researchers Prepare for the Next Pandemic
NVIDIA is collaborating with organizations including Google DeepMind and the European Molecular Biology Laboratory’s European Bioinformatics Institute to release an open dataset of viral protein structures — giving scientists a head start against diseases.
NASA to Study Human Health, Performance During Crew-13 Mission
During NASA's SpaceX Crew‑13 mission aboard the International Space Station, astronauts will support a series of biomedical and human health performance...
The Best Brighton XI of the last 11 seasons
A recent social media trend has seen fans pick out one player from each of the last eleven seasons to build an ultimate starting lineup for their club. Today we attempt this trend for Brighton and Hove Albion.
From the Classroom to the Laboratory: Experiential Learning Shapes Food Science Student’s Future
Two semesters of experiential learning in Rutgers’ food packaging laboratory helped Daniel Burd transform classroom knowledge into award-winning research with real-world applications for the food industry. When Daniel Burd first arrived at Rutgers after earning an associate degree from Brookdale Community College, he knew he loved food science because it brought chemistry and biology to […]
Scientists find two tiny new snails with shells that close like doors
Scientists discovered two tiny new snail species in Montenegro, showing that even Europe still holds animals unknown to science. One lives in the threatened Komarnica Canyon, where a proposed hydropower reservoir could destroy habitat before its full biodiversity is understood.
Orange Boosts Life Science Portfolio With Biolevate Funding
Claire Scotton, VP Healthcare & Life Sciences at Orange, explains that Biolevate can accelerate life sciences innovation with trusted AI and workflows
China is excelling in health tech. That’s good news for the world
Ruby Wang, a physician and biotech consultant in the U.K., on her upcoming book on the emergence of China as a global health superpower.
Why do we get sleepy? Uncovering the science of sleep drive
Why do we get sleepy? A new preclinical study sheds some light on the science of sleep drive.
Milan want Rabiot to commit to long-term contract
Thursday’s reports claim that Milan want midfielder Adrien Rabiot to commit to a new long-term contract, and that the Frenchman could potentially end up seeing his career out in San Siro if he decid...
Under Trump, NIH funding disruptions have evolved. Here's what the numbers show
Stories of science funding being cut, labs shutting down and scientists losing jobs have flooded the media under Trump's administration. These six graphics show how those changes have affected U.S. biomedical research.
Signing Vuskovic was a masterstroke
Luka Vuskovic has been a "masterstroke" addition for Brighton, says former Premier League striker Chris Sutton. Brighton's record signing Vuskovic joined in the summer from Tottenham and has featured in all five of the Albion's Premier League matches so far. "What an incredible signing; £50m from Spurs - Spurs fans must be thinking 'why have we sold this guy?'", Sutton told BBC Radio 5 Live's Monday Night Club.
An AI model has found a new ‘CRISPR-like’ biological system. Here’s what it means for science
After coding, mathematics and chatbots, AI companies are setting their sights on the messy world of biology.
life – the bioRN Life Science Cluster magazine
Alliances for success – Heidelberg and the Rhine-Neckar region are among the most dynamic life science ecosystems in Europe.
Hands-on science can be cool
After spending many long days conducting experiments to find a new way to combat bacterial infections in crops, Misha Hegde and Mia Soleil Maurer have been rewarded with international recognition and access to top research facilities. But these are not typical scientists. They are 16-year-old German high school students.“Our supervisor told us that in order to start a project, you need to begin with either a question or a problem,” says Misha, adding that she and Mia had read about antibiotic resistance in certain plants being treated for bacterial infections. “We found out that antibiotics overuse is very common in agriculture,” explains Mia. “Our aim was to create an alternative to antibiotics and to try to raise awareness of the problem of overusing antibiotics.”Their subsequent research has focused on harnessing bacteriophages, the natural predators of bacteria, to eliminate pathogens threatening food crops treated with antibiotics. At the Schuldorf Bergstraße Jugend forscht MakerLab in Seeheim-Jugenheim, located in the German state of Hesse, they discovered a novel phage that infects the Rhizobium rhizogenes bacterium, which causes the hairy root disease that can reduce yields of tomatoes, carrots, soya beans and other food staples.The students believe their method could curb antibiotic use, while protecting plants from infections without disturbing the natural soil microbiome. “The application of phages is host-specific, so they would only kill the targeted pathogen or disease-causing bacteria,” explains Mia. It may also offer environmental benefits, since applying antibiotics can contaminate groundwater.Getting to this point has not been easy. The childhood friends admit to feeling frustrated when their trials did not yield the expected results. “We spent six months on our first experiment, just doing the same thing over and over and over again, to the point where we thought, is it even worth it? Why are we doing this?” Misha says. “You just need to be brave enough to take that first step and keep going.”The benefits of inquiry-based learningTheir determination has paid off. In 2025, the pair won first prize in biology at Jugend forscht, Germany’s national competition for young people interested in science, technology, engineering and mathematics. They were also among the winners of the German Research Foundation Europa-Preis, which is awarded to selected national winners at Jugend forscht, and took third place in the 2025 European Union Contest for Young Scientists.The Jugend forscht Foundation opens doors for young people to connect with scientists as well as industry professionals. Jessica Bönsch, executive director of the Foundation, sees Misha and Mia as prime examples of how young people can develop a deeper understanding of science through their own research projects. “The experience of working on your own research question is very important,” she explains, adding that “inquiry-based learning engages with real-life problems in a way that can be more motivating than traditional classroom teaching.”The Jugend forscht Foundation offers financial support through sponsor pools in Germany’s federal states. Some projects are developed in cooperation with student research centres, university labs or informal collaborative learning areas called makerspaces. Other activities start as hands-on “garage projects” and can grow within the Jugend forscht network and infrastructure.The Jugend forscht Foundation is also a partner of Science Comes to Town, an EU initiative to strengthen public awareness about science and create bridges between researchers and communities. The EU-financed project involves universities, research institutions and other stakeholders in three host cities — Brest (France), Kiel (Germany) and Split (Croatia).“It's so important for people not to live in a bubble, because I think science can be very scary if you misunderstand it,” Mia says of SCTT. The initiative’s aim of raising awareness about science is “absolutely amazing,” Misha adds. “I think it's the best way to kind of make science digestible for the public. In a world where misinformation in science is getting more radical, more dangerous, becoming more of a threat to the trust in scientific infrastructure and foundations, we need such programmes.”Misha and Mia also believe that SCTT can help break down gender stereotypes in science by encouraging young women to study and pursue careers in scientific fields. Both students have benefited from female mentors and encouragement they had when they were much younger. Mia’s love of science began with a class trip to a lab, while Misha — with a smile on her face — says she wanted to study history until “a teacher kind of coerced me into joining a school science club.”Recognition beyond EuropeIn May, Misha and Mia were among the finalists at the Regeneron International Science and Engineering Fair held in Phoenix, Arizona, and involving nearly 1,700 pre-university students from over 60 countries. “It was very crazy because there were so many people and so many teenagers interested in science,” Mia recalls. The event was also challenging. “It was eight hours of continuously presenting your project,” adds Misha.Attending the fair was a chance for the young women to see first-hand the value of international collaboration as well as how research cultures differ. “America is a bit more willing to take risks, and I think that's something we can learn about here in Europe,” Misha explains. However, she continues, “I think Europe has the talent, has the innovation and has the resources” to be competitive.Misha and Mia plan to continue their phage experiments in the new school year, inspired by the project’s hands-on nature and the support they receive from their supervisors. They have also attracted the interest of professional scientists and received invitations to leading research facilities, including the Centre for Synthetic Microbiology, jointly run by the University of Marburg and the Max Planck Institute for Terrestrial Microbiology in Germany. “It is so cool that we can do something to try to move the world in our school and at this age,” Mia says.After completing secondary school, Mia plans to study microbiology and pursue a career in medical research, focusing on Ebola and other infectious diseases. “This has been my dream for so long,” she says. Her friend Misha is interested in biological research with a focus on medicine. “I've gotten addicted to the process of going to the lab, planning out experiments, then failing, trying again,” Misha says. “I think there's just so much to be discovered, so much to be done.”The students' names and photos were published with the permission of their parents.Science|Business, which connects policymakers, academics and industry through its news reporting, analysis and events, is an SCTT partner.
Biophysical Therapeutics brings longevity science to skincare with its new IF1 brand
From equations and experiments in the laboratory to exclusive skincare for skin longevityWILMINGTON, Del., Sep. 23,
Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models
Recent advances in targeted therapies for pancreatic cancer have brought renewed attention to the Pancreatic Cancer Action Network.
Contrary to some reports, you don't have two brains
A bad press release makes a good excuse to look at how developmental biology works.
13th Session of the Plenary of the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES 13)
13th Session of the Plenary of the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES 13)
DHS plans ‘large investments’ in biosurveillance as it ramps up capabilities
The agency’s Science and Technology Directorate wants to add testing and evaluation sites, forge partnerships with industry and create internal roles to lead the work.
UT Health San Antonio scientists honored with BioMedSA Innovation Awards
Two scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), will be honored with 2026 BioMedSA Innovation in Healthcare and Bioscience awards. The awards recognize San Antonio leaders in the areas of research, clinical innovation, entrepreneurship and lifetime achievement, whose accomplishments improve lives […]
UT Health San Antonio scientists honored with BioMedSA Innovation Awards
Two scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), will be honored with 2026 BioMedSA Innovation in Healthcare and Bioscience awards. The awards recognize San Antonio leaders in the areas of research, clinical innovation, entrepreneurship and lifetime achievement, whose accomplishments improve lives […]
Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models
HOUSTON & SYDNEY, September 23, 2026--The Genialis Supermodel and Inventia's RASTRUM 3D cell model platform together will build models of PDAC that better represent tumor biology.
Troy Clarkson To Deliver Falmouth Forum Season Opener
Author and columnist Troy Clarkson will present the first talk of the Marine Biological Laboratory’s 2026-27 Falmouth Forum series.
Upcoming opportunities
🔬 Know a scientist whose sustained service to ASBMB and professional accomplishments have advanced the molecular biosciences? Consider nominating them as an ASBMB Fellow.
Could Proteins Become the Next Tool in Forensic Science?
Researchers reviewed how forensic proteomics uses mass spectrometry to analyze proteins in hair, bone, fingerprints, and body fluids. The approach can recover biological and contextual information when DNA is limited.
Wildlife management should be based on science not emotion (Opinion)
Wildlife research is essential because it protects biodiversity, guides conservation policies, and helps humans understand complex ecosystems. Without that research wildlife conservation/management and human/wildlife conflict mitigation would be equal to swinging a plastic pool noodle...
Kostoulas & Vuskovic shining for high-flying Seagulls
Brighton are flying high under the youngest manager in the top flight after five games of the Premier League season. Fabian Hurzeler guided his side to a 3-0 victory against Arsenal on the 125-year anniversary of the club in style - and the Seagulls sit in a very pleasing third place in the table. Former Brighton midfielder Warren Aspinall told Radio Sussex's Albion Unlimited podcast that the Gunners were "out-thought and out-battled".
New schizophrenia treatments, AI in mental health among topics at inaugural symposium in Roanoke
The two-day gathering on precision therapeutics will be held at the Fralin Biomedical Research Institute at VTC.
Donald Trump Wants a Vance-Rubio Ticket in 2028, Says Ari Emanuel
Emanuel also believes David Ellison’s doing right by an independent press.
What links smoking, body fat, mental health, genes, and heart risk? Inflammation may be part of the answer
In a large UK Biobank study, higher levels of the chronic inflammation marker GlycA were associated with smaller heart chambers, thicker heart walls, impaired diastolic function, reduced stroke volume, and a 43% higher risk of major adverse cardiovascular events in the highest versus lowest GlycA group. Genetic susceptibility also modified the associations between environmental exposures, inflammation, and cardiovascular risk, while inflammatory proteins in the IL-1, TNF, and IL-6 pathways statistically mediated several of these associations.
Merck Life Science Expands Bengaluru Manufacturing with €13 Million Investment
Merck Life Science is expanding its manufacturing capabilities in Bengaluru with an investment of approximately €13 million, strengthening the company’s ability to supply critical materials to customers across India and the wider Asia-Pacific region. The expansion at Merck Life Science’s Jigani site in Bengaluru will introduce biological buffer manufacturing alongside the facility’s established chemistry capabilities. The investment is designed to enable faster and more reliable access to critical materials used by customers across research, diagnostics, biotechnology and biopharmaceutical manufacturing. The development further advances Merck Life Science’s “in-region, for-region” approach, under which the company is expanding manufacturing capabilities closer to the markets and customers it serves. By adding biological buffer production in India, the Jigani expansion will broaden the site’s manufacturing capabilities while strengthening Merck Life Science’s regional supply infrastructure for the rapidly developing life sciences sector across India and Asia-Pacific. The company said the expansion reflects both the contribution of its teams and its collaboration with government and industry stakeholders. Merck Life Science acknowledged the support of India’s Department for Promotion of Industry and Internal Trade (DPIIT), the German Embassy New Delhi, and Invest India in helping strengthen life science manufacturing capabilities in the region. The investment comes as India continues to expand its role across pharmaceutical, biotechnology, diagnostics and biomanufacturing value chains, increasing demand for dependable regional access to materials supporting research and manufacturing operations. The Bengaluru expansion reinforces Merck Life Science’s focus on building manufacturing capacity within Asia-Pacific and supporting customers through a more regionalised supply network.
Justice Kagan rejects surrogate’s request for intervention in custody dispute
The baby’s biological parents said that high court intervention would only cause chaos and confusion.
Justice Kagan rejects surrogate’s request for intervention in custody dispute
The baby’s biological parents said that high court intervention would only cause chaos and confusion.
Quechan filmmaker explores Native sciences in PBS 'NOVA' episode
The PBS science series "NOVA" will explore Indigenous sciences and how traditional ecological knowledge has nurtured biomes and ecosystems, developed navigation systems using the stars and seas and domesticated foods now consumed worldwide in a new episode featuring Navajo hogan builders and created by a Quechan filmmaker.
Biological sciences professor earns national award for advancing diversity and inclusion in entomology
Dr. Chelsea Cook, assistant professor of biological sciences in Marquette University's Klingler College of Arts and Sciences, has received the 2026 Distinguished Achievement Award in the Promotion of Diversity and Inclusion in the Field of Entomology from the Entomological Society of America.
Supreme Court Order Gives Parents Custody of Baby in Surrogacy Fight
A surrogate refused to have an abortion after the fetus was diagnosed with a serious heart problem. She asked the justices to block a court order giving custody to the biological parents.
Rubio’s meme-worthy job collection takes new turn with permanent Trump upgrade
Trump signed a commission making Secretary of State Marco Rubio his permanent national security adviser, a dual role unseen since the 1970s.
NASA-Funded Research Finds Complex Life Defying Record Heat
NASA-supported scientists have discovered an organism that lives at extreme temperatures previously thought impossible for complex life. High temperatures can
Planetary crisis heightens global inequality of health opportunities
The worldwide inequality of health opportunities is being further heightened by the triple planetary crisis - climate change, loss of biodiversity and environmental pollution.
From paleo to intermittent fasting: are any diets actually good for us?
As diet trends proliferate on social media, it can be hard to work out which are backed by science and which should be ignored. From paleo to keto, raw food to intermittent fasting, each attracts a tribe of ardent followers. Now Daniel Lieberman, professor of biological sciences at Harvard University, has written a book to try to cut through the noise. In Fed Up, he uses his background as an evolutionary anthropologist to scrutinise the evidence, turning himself into a guinea pig in the process and trying various diets. In this podcast, he tells Ian Sample which one has remained part of his routine
This Weird Toad Drove a Brilliant Scientist to His Death. What If He Was Framed?
Paul Kammerer was one of the premier biologists of his generation. But his ideas made him some enemies.
Virtual SUD support platform Nosis launches to address lifestyle, diet needs
Nosis, a platform supporting substance use disorder (SUD) recovery, is launching from stealth in all 50 states. | The virtual startup leverages labs with health coaches and dietitians to address the biological and metabolic health needs of individuals in recovery.
SeaSTORE Scientists Measure Trawling's Impact On Irish Sea Carbon Storage
The SeaSTORE project is conducting real-world research cruises in the Irish Sea to measure how seabed trawling disturbs stored carbon and whether that carbon ultimately reaches the atmosphere. Findings will be shared with UK policymakers to inform net zero, biodiversity, and food security decisions.
Planetary crises deepen global health inequality, paper warns
The global inequality in health opportunities is being further heightened by the triple planetary crisis—climate change, biodiversity loss and environmental pollution. Addressing it is more than a question ...
The UIndy College of Health Sciences Recognizes Outstanding Alumni with 2026 Awards
The University of Indianapolis’s College of Health Sciences (CHS) proudly recognized outstanding alumni who have achieved exceptional success and leveraged their UIndy education to make a significant impact in their field, within their communities, and in the world. This year’s CHS Alumni Awards recipients were: Ralph Reiff '80 (Physical Education, Biology) A first-generation college student,
The UIndy College of Health Sciences Recognizes Outstanding Alumni with 2026 Awards
The University of Indianapolis’s College of Health Sciences (CHS) proudly recognized outstanding alumni who have achieved exceptional success and leveraged their UIndy education to make a significant impact in their field, within their communities, and in the world. This year’s CHS Alumni Awards recipients were: Ralph Reiff '80 (Physical Education, Biology) A first-generation college student,
Club director denies ripping Arsenal off for summer signing
Hamburger SV sporting director Claus Costa has denied ripping Arsenal off for Fabio Vieira, but he conceded that HSV are very happy with the deal they agreed.Photo by Stuart Franklin/Getty ImagesHambu...
Corbion launches second cultured preservation solution
The portfolio now includes Verdad Essence WH150.
San Francisco, it’s neen unBelievable — A message from Jim Pattison Jr., President of Ripley’s Believe It or Not! World Entertainment
For nearly 60 years, Ripley’s Believe It or Not! has been part of the fabric of Fisherman’s Wharf. After careful consideration, we have made the difficult decision to close our current …
Marco Rubio defends Trump’s ban on media outlets from White House, arguing police or soldiers are not ‘kicking down the doors’
“They’re just not allowed to work from the workspace at the White House,” the secretary of state said in an interview on “TODAY,” referring to CNN, Politico and MS NOW.
How Biotechnology Could Protect the Crops We Depend On
Crop biotechnology could protect vital food crops from disease, pests and climate stress, with bananas showing the potential of modern tools.
For the first time, scientists watch sound jump between quantum states
Stanford researchers have recorded the first real-time quantum jumps of sound, watching single phonons abruptly vanish from one energy state to another. The breakthrough could open new paths for quantum computing, error correction, highly sensitive biological sensors, and next-generation sound-based devices.
Wall St futures pause after AI rally, focus on Mideast tensions
Wall Street's main indexes were steady on Tuesday, following strong AI-driven gains in the previous session, while investors awaited potential talks between the United States and Iran that could end their six-month-old conflict.
Is 50 the new 60?
Subscribe TL;DR: Younger generations are showing signs of worse health compared to earlier-born cohorts at the same age This backward “drift” is showing up both in mortality risk and chronic disease Worsening trends in obesity and diabetes are the most consistent signals Taking the long view, we’ve made astonishing gains in health and life expectancy in the last century. Global average life expectancy has more than doubled from 32 years in 1900 to 73 years in 2024. (But don’t forget, there were still old people when life expectancy was 32). As people lived longer, they also generally lived healthier along the way. It turns out that avoiding things that can kill you early, like malnutrition and lots of childhood infections, also keeps you healthier later in life. In a classic 2004 paper, Finch and Crimmins proposed that cohorts of children who benefited from fewer early life infections had less lifetime exposure to inflammation and cardiovascular disease later in life, accelerating mortality improvements at older ages. Poor nutrition in the womb has also been linked to a higher risk of later chronic disease. The upshot is that improvements in childhood health can pay dividends many decades later. The combination of better living conditions (nutrition, sanitation) and medical advances (antibiotics, vaccines, blood pressure meds, etc) meant that people’s healthy lifespan generally expanded, even as they lived longer. Aging researchers call this best-case scenario “compression of morbidity”—meaning we delay the onset of disease and disability even faster than the years of life we are adding. During my 20+ year research career, we could generally bank on the idea that younger generations would not only live longer but also keep getting healthier along the way. “60 is the new 50” as they say… Enter “Generational Health Drift” Sadly, this expectation of steady progress may be changing. You’ve probably heard that US life expectancy gains have slowed to a crawl in the past couple of decades. Mortality improvements are also slowing (though less dramatically) in many other high-income countries (you can read more about that in a review paper I wrote here). Mortality is a very blunt health measure, but it is often a good barometer for the broader population health trends happening underneath. And we are now seeing that younger generations may be in worse health at similar ages compared to earlier born cohorts. My collaborator Prof. George Ploubidis at University College London coined this worsening health in more recently born cohorts “generational health drift.” “Generational health drift” is bad news on multiple fronts. Most obviously, we don’t want our health progress to go backward. But the timing is also bad, since our populations are aging. In demographic terms, “population aging” means that the proportion of the population at older ages (i.e >65 years) is increasing. Fun demography fact: Current population aging is not due to the recent declines in the birth rates making the news, but declines in fertility decades ago, after the “baby boom.” As baby boomers reach older ages, the smaller cohorts behind them mean the percentage of older adults will increase. For example, the share of the population age 65 and older in the US increased from 12.4% in 2004 to 18.0% in 2024. This story of population aging was written long ago. Many worry that population aging will put pressure on health care and pension systems. But if people reach older ages in better health than in years past, those fiscal pressures would be less dire than projected. Healthy older people can also continue to contribute to society in many valuable ways, including paid work, caregiving, community service….even high political office 🤷. On the flip side, if younger generations reach retirement age in worse health and with more disabling conditions, this could magnify the societal challenge of population aging. Evidence for worsening generational health A recent paper that I LOVED in the Proceedings of the National Academy of Sciences by Dr. Leah Abrams and colleagues examined which birth cohorts (aka generations) were behind worsening US mortality. Behold the Lexis diagram (cue swooning demographers). Calendar time is on the x-axis, age on the y-axis. Birth cohorts can be followed over time as they age on the diagonal lines moving up and to the right. This figure plots the year-on-year % change in all-cause mortality at a given age. Green shading indicates mortality improvements over time, white is stagnation, and gray shading indicates worsening mortality. Following the diagonal line for those born in 1950, you can see a noticeable shift from green to gray that follows this cohort for most of their lives. This gray shading shows generally worsening mortality for the 1950 to 1959 birth cohorts compared to their predecessors across all ages. Concerningly for my GenX and elder millennial peeps, there was also a deterioration in mortality for birth cohorts born in the 1970s and 1980s, visible as dark gray areas at ages 30 to 45 during the 2010s. While some of these mortality changes reflect specific shocks such as the opioid epidemic, most deaths still occur from major causes of death such as cardiovascular disease and cancer. For cancer, the gray in the top left corner of the figure below reflects the legacies of smoking for older cohorts, followed by a period of green with improvements in cancer mortality as smoking rates declined. But the white/gray shading in the bottom right corner highlights a stagnation and reversal of the cancer trends, with cohorts born around 1970 to 1985 experiencing worsening cancer mortality. This deterioration was most noticeable for colon cancer mortality, possibly linked to obesity or dietary factors. Not just dying more, but less healthy along the way. A recent paper by Dr. Laura Gimeno of University College London (of which I am a co-author), found evidence that more recently born cohorts in Great Britain have stagnating or worsening health. A stylized picture of what“generational health drift” might look like: The review paper found: Rates of childhood overweight and obesity were highest among Gen Z. Rates of diabetes in the 40s almost doubled from 3.1% among the Baby Boomers to 5.9% in Generation X. Gen Z reported higher rates of poor mental health in adolescence compared to earlier-born groups. These UK results are consistent with studies showing worsening health across generations in the US as well. A 2021 US study found that more recently born cohorts had worse biological markers (like blood pressure and blood sugar) than earlier generations at the same age. A separate 2022 study of Americans aged 50 and over found that more recently born generations had a higher number of chronic diseases, with younger age of disease onset. A 2024 Lancet paper found that in the US, women born in 1945 had 33% obesity prevalence at age 50, rising to 48.2% for women born in 1970 turning 50. So what’s going on, and can we turn it around? We don’t have a definitive answer for what’s causing the deteriorating health of younger cohorts, but circumstantial evidence points to worsening trends in obesity and diabetes in both the US and UK. Remember that cohort trends reflect lagged effects of early environments, and younger generations have faced both earlier onset and more severe obesity across their lifetimes. Despite these very concerning trends, the future is not set in stone. We’ve reversed poor generational health trends before: drops in smoking are a major reason cancer and heart disease deaths fell so dramatically in recent decades. GLP-1 drugs may finally turn the tide against rising rates of obesity and diabetes, though it is still early days. But things could also get worse…for example from a return to higher levels of childhood infectious diseases that can have a lasting impact on health. See for example: [ ](https://jenndowd.substack.com/p/dont-you-forget-about-measles-the) [ Don’t You Forget About Me(asles): The Virus That Erases Immune Memory ](https://jenndowd.substack.com/p/dont-you-forget-about-measles-the) Jenn Dowd, PhD · March 24, 2025 [ Read full story ](https://jenndowd.substack.com/p/dont-you-forget-about-measles-the) Even as an optimist, emerging data on the “generational health drift” has my full attention. For most of my research career, we took it for granted that each generation would be healthier than the last. But if present trends continue, **50 could be the new 60….**and Gen Z celebrities will soon look older than Paul Rudd :). Stay well, Jenn Share the Health! If you found this post useful, please share it with a friend. Share
Backyard Biodiversity: Recent Soil Science Insights Enlarge Understanding Of Why Plant Diversity Delivers Benefits
Plant diversity. Courtesy photo BY OWEN HABLUTZELFor Chama Peak Land Alliance’s Backyard Biodiversity series Plant diversity has a very long, widespread history of human use as a strategy for…
Polystyrene nanoplastics may threaten reproductive health and offspring development
Plastic pollution is increasingly being recognized as more than an environmental problem. Tiny plastic particles can enter living organisms, circulate through biological systems, and potentially reach reproductive tissues.
Laura Bruner Honored with 2026 Allen D. Leman Science in Practice Award
Swine Vet Center veterinarian recognized for leadership in swine health, biosecurity and practical disease management.
UWA awarded National Institutes of Health funding for research equipment
A grant from the National Institutes of Health is making way for new biomedical research opportunities for students and faculty at the University of West Alabama. The funding is UWA’s first National Institutes of Health (NIH) award, marking a significant milestone in the institution’s research growth.
Anthropic Eases AI Safeguards for Verified Life Science Teams
Sept. 21, 2026 — Anthropic has introduced the Life Sciences Verification Program (LSVP), which gives life science professionals access to Mythos, Opus, and Sonnet models with a refined set of safeguards more permissive for biology-related work. Dozens of organizations have already been onboarded through an early-access program, and applications are now open to the broader life […]
Rubio rings opening bell at New York Stock Exchange to begin UN General Assembly
Secretary of State Marco Rubio began the United Nations General Assembly, a major week in diplomacy, by ringing the opening bell at the New York Stock Exchange on Monday. The ceremony serves as a time marker, signaling the start and closing of an official session. The bells were first used at the exchange in the […]
The College of Arts and Sciences Announces Its Fall 2026 Sir Run Run Shaw Lecture Series
The College of Arts and Sciences presents the Fall 2026 Sir Run Run Shaw Lecture Series, which kicks off on Thursday, September 24, with two lectures: “1.5; or, on the necessity of the humanities in nihilistic times,” featuring Jarrett Zigon, University of Virginia; and “Visible Ink: The Art of Black Women's Literary Biography," featuring Dana
MBARI and Synchro Join Global Workshop to Tackle Deep-Sea Science Challenges
MBARI and Synchro staff joined nearly 70 experts from 22 countries at the Deep Ocean Collective Solution Accelerator, a four-day DOOS-convened workshop at Scripps Institution of Oceanography focused on biodiversity data access, affordable ocean technology, seafloor video analysis, and BBNJ Agreement implementation.
Halo 3, Mass Effect, BioShock, Rock Band, and More: Fall 2007 Was the Greatest Season in Xbox – and Also Gaming
The fact that you can slice up the Fall of 2007 in so many different ways – best Xbox season ever, best PC season ever, best November ever – and the argument for its unmatched brilliance still holds up is iron-clad proof that it is, indisputably, the best season in video game history.
Europe has the science. Now it needs a clinical trials system to match.
Europe has the scientific expertise to lead the next generation of cancer research, but slow and fragmented clinical trial processes, particularly in the case of multinational trials, are not allowing it to reach its full potential. The EU Biotech Act can address the existing bottlenecks to turn this excellence into faster research, stronger competitiveness and earlier opportunities for patients.
Which Came First, The Chicken Or The Egg? Scientists Finally Have The Answer
Philosophers have wrestled with this riddle for centuries, but evolutionary biology has quietly been building a case that rewrites the entire question. The answer turns out to hinge on a single, stran...
Business Group on Health taps BioRadar to boost workforce readiness for emerging threats
Biological threat intelligence is increasingly becoming a workforce and business issue, not just a public health concern. | Biological threat intelligence is increasingly becoming a workforce and business issue, not just a public health concern. Emerging threats—infectious disease outbreaks, pandemics and potential bioterrorism events—can cause workforce and operational disruptions.
Business Group on Health taps BioRadar to boost workforce readiness for emerging threats
Biological threat intelligence is increasingly becoming a workforce and business issue, not just a public health concern. | Biological threat intelligence is increasingly becoming a workforce and business issue, not just a public health concern. Emerging threats—infectious disease outbreaks, pandemics and potential bioterrorism events—can cause workforce and operational disruptions.
The 5 daily habits that science says can slow biological aging
Five daily habits that research links to slower biological aging, covering exercise, sleep quality, diet, stress management and social connection
Our worst performance of the season
West Bromwich Albion defender Conor Townsend labels their Black Country derby 1-0 loss to Wolverhampton Wanderers their "worst performance of the season".
Hanx Biopharmaceuticals (Wuhan) Enters Agreement To Explore AI For Science In Drug Research
Hanx Biopharmaceuticals (Wuhan) Co Ltd HKEX:3378:
Transformative Biological and Environmental Frontiers: Synthesizing the 2026 Tang Prize Science Laureates
The Tang Prize in Sustainable Development and Biopharmaceutical Science honors pivotal scientific advances that improve global health, restore damaged ecosystems, and deliver transformative medical treatments. The 2026 science laureates, Professor Susan Solomon for Sustainable Development, along with Dr. Steven A. Rosenberg, Dr. Michel Sadelain, and Dr. Carl H. June for Biopharmaceutical Science, demonstrate how disciplined